Insiders · Profile

PYOTT DAVID E I

Director at ALNYLAM PHARMACEUTICALS · Director at BIOMARIN PHARMACEUTICAL · Director at Avery Dennison · and 1 more. Filing since 18 Feb 2010. CIK 0001051578

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jun 2026
Director
Sold on a plan
3,830
$1.15M
70.8%
24 Mar 2025
Director
Sold on a plan
7,440
$2.22M
98.2%
24 Jun 2024
Director
Sold on a plan
32,450
$7.16M
99.6%
31 Aug 2020
Director
Bought
12,800
$1.00M
71.3%
3 Feb 2020
Director
Sold, plan not stated
5,027
$667.18K
22.5%
27 Nov 2018
Director
Sold, plan not stated
2,000
$186.00K
11.6%
30 Aug 2017
Director
Sold, plan not stated
1,702
$159.99K
9.5%
28 Aug 2017
Director
Sold, plan not stated
298
$28.01K
1.8%
13 Oct 2016
Director
Bought
27,900
$1.03M
opened
8 Aug 2016
Director
Sold, plan not stated
2,000
$157.22K
12.5%
2 Nov 2015
Director
Sold, plan not stated
2,000
$129.76K
14.9%
1 May 2013
Director
Bought
3,000
$188.85K
6.6%
6 Aug 2012
Director
Sold, plan not stated
6,798
$684.20K
13.0%
18 Jan 2012
Director
Sold, plan not stated
20,000
$1.54M
31.7%
19 Nov 2010
Director
Sold, plan not stated
37,806
$2.50M
48.1%
18 Nov 2010
Director
Sold, plan not stated
10,392
$685.87K
11.7%
11 Nov 2010
Director
Sold, plan not stated
7,126
$465.54K
7.4%
18 Feb 2010
Director
Sold, plan not stated
15,729
$1.42M
36.6%
18 decisions on file.